• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Exclusive

Krishna Institute IPO subscribed 3.86 times on last day of subscription

The Krishna Institute IPO received bids for 5,56,55,046 shares as against 1,44,13,073 shares on offer, as per NSE data

  • Press Trust of India
  • Last Updated : June 18, 2021, 19:44 IST
  • Follow
GLS is a leading developer and manufacturer of select high value, non-commoditised active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management and diabetes.
  • Follow

New Delhi: The initial public offer of Krishna Institute of Medical Sciences Limited was subscribed 3.86 times on the last day of subscription on Friday. The Krishna Institute IPO received bids for 5,56,55,046 shares as against 1,44,13,073 shares on offer, as per NSE data.

The portion meant for Qualified Institutional Buyers(QIBs) was subscribed 5.26 times, non-institutional investors 1.89 times, and retail individual investors(RIIs) 2.89 times.

The initial public offer (IPO) comprised a fresh issue of up to Rs 200 crore and an offer for sale of up to 2,35,60,538 equity shares. The price range for the offer was at Rs 815-825 per share. Krishna Institute of Medical Sciences Ltd on Tuesday raised over Rs 955 crore from anchor investors.

The equity shares of the company are proposed to be listed on BSE and NSE. Krishna Institute of Medical Sciences (KIMS) is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered.

Kotak Mahindra Capital Company, Axis Capital, Credit Suisse Securities (India), and IIFL Securities were the managers of the offer.

Published: June 18, 2021, 19:44 IST

Download Money9 App for the latest updates on Personal Finance.

  • IPO
  • KIMS
  • KIMS IPO

Related

  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • भारत-रूस समिट में बड़े फैसलों की तैयारी, इकोनॉमिक पार्टनरशिप पर बड़ा फोकस
  • भारत और यूरोपीय संघ के बीच पैसे भेजना होगा आसान,RBI ने शुरू की UPI TIPS; जानें कैसे करेगा काम
  • श्रम संहिता लागू होने से निर्यातकों को मिलेगा प्रोत्साहन: अधिकारी
  • मारुति सुजुकी ने प्रौद्योगिकी स्टार्टअप में करीब आठ प्रतिशत हिस्सेदारी हासिल की
  • टोयोटा ने डैशबोर्ड के हिस्से को बदलने के लिए 11.5 हजार अर्बन क्रूजर हाइडर वापस मंगाईं

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close